Novartis Reports Double-Digit Sales Growth In Q2, Raises Full-Year Guidance
Novartis has reported a robust financial performance for the second quarter of 2025, with net sales reaching USD 14.1 billion, up 12 percent year-on-year.
Core Operating Income | 17/07/2025 | By Dineshwori | 365
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy